![3,9-diazatricyclo[8.4.0.0³,·]tetradeca-1(14),4,6,10,12-pentaene](https://static.cymitquimica.com/products/3D/img/XAA16253.png "Haga clic para ampliar")
3,9-diazatricyclo[8.4.0.0³,·]tetradeca-1(14),4,6,10,12-pentaene
CAS: 22162-53-4
Ref. 3D-XAA16253
| 1g | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
3,9-diazatricyclo[8.4.0.0³,·]tetradeca-1(14),4,6,10,12-pentaene
Sinónimos:
- 10,11-Dihydro-5H-Benzo[E]Pyrrolo[1,2-A][1,4]Diazepine
- 5H-Pyrrolo[2,1-c][1,4]benzodiazepine, 10,11-dihydro-
Descripción:
Lixivaptan is a cation that is structurally related to vasopressin, a hormone that regulates water balance. Lixivaptan is a lixivaptan-arginine complex. It has been found to be an antagonist of the vasopressin receptor, thereby preventing the binding of vasopressin and its subsequent effects in the body. Lixivaptan has been investigated for use in patients with heart failure who have low blood volume and/or pressure due to reduced production of vasopressin or natriuretic peptide. The compound is orally administered, with hydrazine and chloride as active compounds. It has been shown to be effective in laboratory animals at high doses.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
184.24 g/mol
Fórmula:
C12H12N2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
